Canaud Ludovic, Gandet Thomas, Ozdemir Baris Ata, Albat Bernard, Marty-Ané Charles, Alric Pierre
Department of Thoracic and Cardio-Vascular Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.
Department of Thoracic and Cardio-Vascular Surgery, Arnaud de Villeneuve Hospital, Montpellier, France.
Ann Vasc Surg. 2016 Jan;30:175-80. doi: 10.1016/j.avsg.2015.07.046. Epub 2015 Oct 31.
The aim of this study was to evaluate the short-term and midterm results of hybrid repair of dissecting aortic arch aneurysms subsequent to surgical treatment of acute type A dissections.
Between 2003 and 2014, 7 consecutive patients, previously operated for acute type A dissection, underwent hybrid repair of their aortic arch for a dissecting aortic arch aneurysm (6 men, mean age 62 ± 11 years). Aneurysm formation requiring treatment in these aortic arches was observed from 2 to 20 years after the initial aortic dissection repair. A hybrid technique was used in all patients, with supra-aortic debranching through a redo sternotomy and either simultaneous (6 patients) or staged endovascular stent grafting (1 patient). Two patients were treated in an emergent setting (1 ruptured and 1 symptomatic aneurysm). Two patients required a more extensive aortic repair of either the thoracic aorta (n, 1) or of the thoracoabdominal aorta (n, 1). One patient underwent, saphenous vein bypass from the ascending aorta to the anterior descending coronary artery on full cardiopulmonary bypass. Follow-up computed tomography scans were performed at 1 week, 3, and 6 months, and annually thereafter.
Technical success was achieved in all the cases. One transient ischemic attack, 1 stroke, and 1 episode of transient spinal cord ischemia were observed. Thirty-day mortality was not observed. A type I endoleak at 6 months was successfully treated with deployment of a second stent graft. After a mean follow-up of 3.5 ± 3.1 years (range, 0.4-9.6 years), no aortic-related mortality was observed. No cases of stent-graft migration or secondary rupture were observed.
Our experience demonstrates the promising potential of endovascular repair of dissecting aortic arch aneurysms after surgical treatment of acute type A dissection. The potential to diminish the magnitude of the surgical procedure and the consequences of aortic arch exposure, and above all avoiding the need for circulatory arrest are promising and mandate further investigation to determine the efficacy and durability of this technique.
本研究旨在评估急性A型主动脉夹层手术治疗后,主动脉弓夹层动脉瘤杂交修复术的短期和中期结果。
2003年至2014年期间,7例曾接受急性A型主动脉夹层手术的患者,因主动脉弓夹层动脉瘤接受了杂交修复术(6例男性,平均年龄62±11岁)。在初次主动脉夹层修复术后2至20年观察到这些主动脉弓出现需要治疗的动脉瘤形成。所有患者均采用杂交技术,通过再次开胸手术进行主动脉弓上血管分支离断,并同时(6例患者)或分期进行血管内支架植入术(1例患者)。2例患者在急诊情况下接受治疗(1例为破裂动脉瘤,1例为有症状动脉瘤)。2例患者需要对胸主动脉(1例)或胸腹主动脉(1例)进行更广泛的主动脉修复。1例患者在全心肺转流下接受了从升主动脉到前降支冠状动脉的大隐静脉搭桥术。术后1周、3个月、6个月进行随访计算机断层扫描,此后每年进行一次。
所有病例均获得技术成功。观察到1例短暂性脑缺血发作、1例中风和1例短暂性脊髓缺血发作。未观察到30天死亡率。术后半年出现的I型内漏通过植入第二个支架成功治疗。平均随访3.5±3.1年(范围0.4 - 9.6年)后,未观察到与主动脉相关的死亡。未观察到支架移植物移位或二次破裂的病例。
我们的经验表明,急性A型主动脉夹层手术治疗后,主动脉弓夹层动脉瘤的血管内修复具有广阔前景。减少手术规模和主动脉弓暴露后果的潜力,尤其是避免循环停止的必要性很有前景,需要进一步研究以确定该技术的有效性和耐久性。